Engineered T cells for cancer therapy

被引：95
|
作者：
June, Carl H. [1 ,2 ]
Maus, Marcela V. [1 ,3 ]
Plesa, Gabriela [1 ]
Johnson, Laura A. [1 ,2 ]
Zhao, Yangbing [1 ,2 ]
Levine, Bruce L. [1 ,2 ]
Grupp, Stephan A. [1 ,4 ]
Porter, David L. [1 ,3 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 2014年 / 63卷 / 09期
关键词：
Adoptive cell transfer; Gene transfer; Leukemia; Chimeric antigen receptor; 19th Danish Cancer Society Symposium; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; GENE-THERAPY; TOXICITY; REGRESSION; CD28; SPECIFICITY; PERSISTENCE; ACTIVATION; EXPRESSION;
D O I：
10.1007/s00262-014-1568-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities, is the subject of this focused research review.
引用
收藏
页码：969 / 975
页数：7
相关论文
共 50 条
  • [21] Microencapsulation of genetically engineered cells for cancer therapy
    Löhr, JM
    Saller, R
    Salmons, B
    Günzburg, WH
    GENE THERAPY METHODS, 2002, 346 : 603 - 618
  • [22] Engineered T cells for pancreatic cancer treatment
    Katari, Usha L.
    Keirnan, Jacqueline M.
    Worth, Anna C.
    Hodges, Sally E.
    Leen, Ann M.
    Fisher, William E.
    Vera, Juan F.
    HPB, 2011, 13 (09) : 643 - 650
  • [23] Genetically engineered T cells for cancer immunotherapy
    Dan Li
    Xue Li
    Wei-Lin Zhou
    Yong Huang
    Xiao Liang
    Lin Jiang
    Xiao Yang
    Jie Sun
    Zonghai Li
    Wei-Dong Han
    Wei Wang
    Signal Transduction and Targeted Therapy, 4
  • [24] Future perspectives on engineered T cells for cancer
    Posey, Avery D., Jr.
    Young, Regina M.
    June, Carl H.
    TRENDS IN CANCER, 2024, 10 (08) : 687 - 695
  • [25] Genetically engineered T cells for cancer immunotherapy
    Li, Dan
    Li, Xue
    Zhou, Wei-Lin
    Huang, Yong
    Liang, Xiao
    Jiang, Lin
    Yang, Xiao
    Sun, Jie
    Li, Zonghai
    Han, Wei-Dong
    Wang, Wei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [26] Mesenchymal stem cells engineered for cancer therapy
    Shah, Khalid
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (08) : 739 - 748
  • [27] Genetically engineered T cells for the treatment of cancer
    Essand, M.
    Loskog, A. S. I.
    JOURNAL OF INTERNAL MEDICINE, 2013, 273 (02) : 166 - 181
  • [28] Adoptive Cell therapy with gene engineered T cells
    Shiku, Hiroshi
    CANCER SCIENCE, 2021, 112 : 965 - 965
  • [29] Engineered T cells: the promise and challenges of cancer immunotherapy
    Fesnak, Andrew D.
    June, Carl H.
    Levine, Bruce L.
    NATURE REVIEWS CANCER, 2016, 16 (09) : 566 - 581
  • [30] Genome Editing in Engineered T Cells for Cancer Immunotherapy
    Bonini, Chiara
    Chapuis, Aude G.
    Hudecek, Michael
    Guedan, Sonia
    Magnani, Chiara
    Qasim, Waseem
    HUMAN GENE THERAPY, 2023, 34 (17-18) : 853 - 869
12345